Epcoritamab

Definition: Epcoritamab, sold under the brand name Epkinly, is a Bi-specific T-cell engager (BiTE) used for the treatment of diffuse large B-cell lymphoma. Epcoritamab is a bispecific CD20-directed CD3 T-cell engager. source: Wikipedia

ID

1363209009

ID date

6 Oct 2025

Previous ID

42501111000001106

Name

Epcoritamab